Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Specialty Pharma ApS
APS
Active
Reklamebeskyttelse
CVR 38476599
Parcelvej 11, 2840
Holte
Business and other management consultancy activities
·
NACE 7020
Est. 2017 · 9 years old
1 employees
www.specialtypharma.dk
Overvåg
Share
Denmark
/
Companies
/
Business and other management consultancy activities
/
Specialty Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
639
1.023
293
96
217
Staff expenses
-705
-963
-184
-157
-287
EBITDA
-65
60
109
-61
-71
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-65
60
109
-61
-71
Net financials
-0
-2
0
-2
-0
Profit before tax
-66
58
109
-63
-71
Tax
-22
17
28
-9
-13
Net profit
-44
41
81
-54
-59
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
124
116
180
158
86
Equity
-27
14
95
41
-18
Long-term debt
0
0
0
0
0
Short-term debt
151
102
86
117
104
Total debt
151
102
86
117
104
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-32.6%
This company
2021
2025
Soliditetsgrad
-20.8%
This company
38.2%
Market median
-154% vs market
2021
2025
Egenkapitalforrentning
-5856600.0%
This company
18.4%
Market median
-31829448% vs market
2021
2025
Nettoresultatgrad (af bruttofortjeneste)
-27.0%
This company
2021
2025
Aktivomsætning (af bruttofortjeneste)
2.53×
This company
2021
2025
Gæld/egenkapital
5.82×
This company
0.62×
Market median
-839% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Specialty Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
